Quoin Pharmaceuticals Statistics

Total Valuation

QNRX has a market cap or net worth of $4.22 million. The enterprise value is -$943,557.

Market Cap	4.22M
Enterprise Value	-943,557

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

QNRX has 588,166 shares outstanding. The number of shares has increased by 477.30% in one year.

Current Share Class	n/a
Shares Outstanding	588,166
Shares Change (YoY)	+477.30%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	74.69%
Owned by Institutions (%)	1.61%
Float	117,946

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.66
P/TBV Ratio	1.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 1.03.

Current Ratio	1.95
Quick Ratio	1.80
Debt / Equity	1.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -242.66% and return on invested capital (ROIC) is -99.86%.

Return on Equity (ROE)	-242.66%
Return on Assets (ROA)	-69.03%
Return on Invested Capital (ROIC)	-99.86%
Return on Capital Employed (ROCE)	-277.23%
Revenue Per Employee	n/a
Profits Per Employee	-$2.43M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.52% in the last 52 weeks. The beta is 1.82, so QNRX's price volatility has been higher than the market average.

Beta (5Y)	1.82
52-Week Price Change	-61.52%
50-Day Moving Average	8.37
200-Day Moving Average	13.15
Relative Strength Index (RSI)	40.32
Average Volume (20 Days)	4,358

Short Selling Information

Short Interest	9,000
Short Previous Month	9,152
Short % of Shares Out	1.53%
Short % of Float	7.63%
Short Ratio (days to cover)	2.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.68M
Pretax Income	-8.28M
Net Income	-12.17M
EBITDA	-12.58M
EBIT	-12.68M
Earnings Per Share (EPS)	-$32.59

Full Income Statement

Balance Sheet

The company has $7.79 million in cash and $2.62 million in debt, giving a net cash position of $5.17 million or $8.78 per share.

Cash & Cash Equivalents	7.79M
Total Debt	2.62M
Net Cash	5.17M
Net Cash Per Share	$8.78
Equity (Book Value)	2.55M
Book Value Per Share	4.34
Working Capital	4.14M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.70M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-477.30%
Shareholder Yield	-477.30%
Earnings Yield	-288.16%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:35.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	1:35

Scores

Altman Z-Score	n/a
Piotroski F-Score	2